Biotech Values

[Cactus Quave]

Curiously absent from Teva’s PR today is an assertion that Teva expects FDA approval.

Given that Teva has publicly stated several times in the past that they do expect approval, the lack of that assertion in today's PR is, as you state, curious. They seem to be dancing around that omission by implying at final product approval is fait accompli if they can just get the responses in to that short list of questions. Oddly enough, today's PR from Teva strikes me as a cleverly disguised step back from their assertions over the last few months.